Cardiovascular Diseases
Conditions
Interventions
None listed
Sponsors
Shimane University Faculty of Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Patients aged >=18 years at the time of obtaining informed consent (regardless of sex). 2) Patients admitted to the Department of Cardiovascular Medicine at Shimane University Hospital for evaluation and treatment of acute coronary syndrome, acute heart failure, valvular heart disease, arrhythmia, or cardiomyopathy. 3) Patients who were engaged in some form of employment prior to admission (including full-time employment, part-time/non-regular employment, or self-employment), or who express a desire to work after discharge. 4) Patients who, after receiving a full explanation of the study and demonstrating sufficient understanding, provide written informed consent of their own free will to participate in this study.
Exclusion criteria
Exclusion criteria: 1) Patients admitted solely for planned treatments (e.g., elective PCI, ablation, TAVI, MitraClip) or for diagnostic evaluation. 2)Patients in whom continuation of employment is considered medically difficult due to severe comorbidities, progressive malignancy, end-stage renal failure, or similar conditions. 3) Patients for whom completion of questionnaires or follow-up is difficult due to advanced dementia or severe psychiatric disorders. 4) Patients whom the attending physician judges to have a life expectancy of less than 6 months at the time of study enrollment. 5) Patients expected to relocate overseas, be lost to follow-up (e.g., unknown contact information), or require prolonged hospitalization. 6) Patients deemed inappropriate for participation in this study by the attending physician or the principal investigator for any other reason.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The return-to-work rate at 1 year after discharge. | — |
Secondary
| Measure | Time frame |
|---|---|
| (1) Work-related measures: Contents of the employment-related questionnaire, International Physical Activity Questionnaire, Work Productivity and Activity Questionnaire, and the Brief Job Stress Questionnaire (2) Clinical outcomes: All-cause mortality, cardiovascular mortality, all-cause readmission, heart failure readmission, unscheduled visits, and major adverse cardiovascular events (MACE: a composite of cardiovascular death, myocardial infarction, and stroke) (3) Physical function and quality of life (QOL): Changes in the Clinical Frailty Scale, changes in the Barthel Index, changes in the European Heart Failure Self-Care Behavior Scale Japanese version, and changes in the EQ-5D-5L (4) Exploration of factors associated with return to work and work retention: Patient background, treatment details for cardiovascular disease, clinical findings, laboratory findings, findings from exercise function tests, and contents of multidisciplinary conferences | — |
Countries
Japan
Contacts
Public ContactJunya Tanabe
Shimane University Faculty of Medicine Cardiology
Outcome results
None listed